Press release
Pegfilgrastim Biosimilars Market: Rapid Growth, Major Drivers, and Emerging Trends Forecast 2025-2029
Pegfilgrastim Biosimilars Market Size
What Is The Projected Market Size Of The Global Pegfilgrastim Biosimilars Market And Its Growth Rate?
The pegfilgrastim biosimilars market has experienced significant growth recently. Key statistics include:
•Market size in 2024: $1.56 billion
•Projected Market size in 2025: $1.8 billion (CAGR 15.3%)
•Forecast Market size in 2029: $3.44 billion (CAGR 17.5%)
This growth can be attributed to increasing prevalence of cancer, aging population, increasing number of approvals, and targets and incentives.
What Is Driving The Growth In The Pegfilgrastim Biosimilars Market?
Government initiatives worldwide promoting the development of cost-effective biosimilars are driving the growth of the pegfilgrastim biosimilars market. For instance, the US Food and Drug Administration (FDA) launched a Biosimilar Action Plan to increase treatment options. Similarly, the Australian government, dedicated to the Biosimilar Awareness Initiative, provided a grant of $5 million to support the Generic and Biosimilar Medicines Association for encouraging greater awareness and appropriate use of biosimilar medicines. These initiatives aid in boosting the production and awareness of biosimilars, thereby supporting the growth of the pegfilgrastim biosimilars market.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4015&type=smp
Who Are The Key Players Driving Pegfilgrastim Biosimilars Market Growth?
Key players in the pegfilgrastim biosimilars market include:
•Amgen
•Mylan N.V.
•Sandoz
•Teva Pharmaceutical Industries Ltd.
•Biocon
•Pfizer
•Celltrion Healthcare
•Coherus BioSciences
•Gedeon Richter
•Fresenius Kabi
•Hetero Labs
•Intas Pharmaceuticals
What Are The Key Trends In The Pegfilgrastim Biosimilars Market?
Key trends emerging in the pefilgrastim biosimilars market:
•Utilizing less stringent regulations to develop new and improved biosimilars
•Extensive investment in R&D for innovative and effective biologics
•Strategic partnerships for expanding research and new drug development
•Focus on M&A for customer and geographic market expansion
•Increasing focus on biosimilars for neutropenia treatment to boost revenues and product offerings
What Are The Segments Of The Global Pegfilgrastim Biosimilars Market?
The report categorizes the global pegfilgrastim biosimilars market into:
1) By Application: Chemotherapy Treatment, Transplantation, Other Applications
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Mail-Order Pharmacies
Which Region Leads The Pegfilgrastim Biosimilars Market?
North America was the largest region in the pegfilgrastim biosimilars market in 2024. The Middle East is expected to emerge as the fastest growing region during the forecast period. The market report covers Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/pegfilgrastim-biosimilar-global-market-report
What Is Covered In The Pegfilgrastim Biosimilars Market Global Market Report?
- Market Size Analysis: Analyze the Pegfilgrastim Biosimilars Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Pegfilgrastim Biosimilars Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Pegfilgrastim Biosimilars Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Pegfilgrastim Biosimilars Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report
https://www.thebusinessresearchcompany.com/customise?id=4015&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pegfilgrastim Biosimilars Market: Rapid Growth, Major Drivers, and Emerging Trends Forecast 2025-2029 here
News-ID: 3838983 • Views: …
More Releases from The Business Research Company
Segmentation, Major Trends, and Competitive Overview of the Space Resource Utili …
The exploration and utilization of space resources is rapidly evolving into a promising sector with vast potential for growth and innovation. As technology advances and partnerships form, the industry is set to transform how humanity accesses and uses materials beyond Earth, paving the way for sustainable off-world operations and broader space exploration.
Projected Market Growth for Space Resource Utilization
The space resource utilization industry is anticipated to experience significant expansion over…
Market Trend Analysis: The Impact of Recent Advances on the Space Law Enforcemen …
The growing complexity and activity in outer space have brought increased attention to the need for effective space law enforcement. As the number of satellites and space missions rises, managing space traffic and ensuring compliance with regulations becomes critical. This overview explores the future outlook, driving factors, major players, and structural breakdown of the space law enforcement market as it progresses toward 2030.
Expected Growth Trajectory of the Space Law Enforcement…
Market Structure, Emerging Trends, and Key Player Analysis in Space Elevator Ope …
The concept of space elevators is rapidly moving from science fiction to a tangible future technology, promising revolutionary changes in how we access and utilize space. As interest and investment in this area grow, the market for space elevator operations is set to expand significantly. Below is an overview of the forecasted market size, key players, emerging trends, and the segmentation of this exciting industry.
Projected Market Growth of Space Elevator…
Competitive Analysis: Leading Companies and New Entrants in the Space Currency a …
The emerging space currency and economy sector is poised for remarkable expansion as humanity's ventures beyond Earth gain momentum. With innovations in financial technologies tailored for the unique challenges of space commerce, this market is set to transform how transactions and economic activities unfold across orbital and interplanetary environments. Let's explore the projected growth, key players, market drivers, evolving trends, and the detailed segmentation shaping this futuristic industry.
Projected Market Size…
More Releases for Biosimilar
Interchangeable Biosimilar Humira Market Share Driven by Biologic Therapy Adopti …
Interchangeable Biosimilar Humira Market
The global market for Interchangeable Biosimilar Humira was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period
View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-33I15005/Global_Interchangeable_Biosimilar_Humira_Market_Research_Report_2023
The Interchangeable Biosimilar Humira Market is experiencing significant market growth as healthcare providers and patients increasingly adopt biosimilar therapies for autoimmune and inflammatory conditions. Market trends indicate rising…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market?
In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial…
Biosimilar Market Treating More for Less: The Booming Infliximab Biosimilar Mark …
Infliximab Biosimilar Market worth $ XX Million by 2030 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Infliximab Biosimilar Market- by Application (Crohn's Disease, Psoriatic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis, Ankylosing Spondylitis, Plaque Psoriasis and Others), End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Other Direct Distribution Channels), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get…
Biosimilar Monoclonal Antibodies Market
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " "Global Biosimilar Monoclonal Antibodies Market by Product (infliximab, trastuzumab, rituximab, adalimumab, bevacizumab, cetuximab, ranibizumab, denosumab, eculizumab, and other pipeline products), Indication (oncology, inflammatory & autoimmune disorders, chronic diseases, blood disorders, and other indications), Clinical Trial/Pipeline Analysis, Future Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
The Biosimilar Monoclonal Antibodies Market Size is valued at 5.02…
Infliximab Biosimilar Insight, 2022 | DelveInsight
DelveInsight's, "Infliximab Biosimilar Insight, 2022" report provides comprehensive insights about 35+ companies and 45+ marketed and pipeline drugs in Infliximab Biosimilars landscape. It covers the marketed and pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Interested to know more about the functioning of…
